PD-1 blockade in recurrent or metastatic cervical cancer: Data from cemiplimab phase I expansion cohorts and characterization of PD-L1 expression in cervical cancer.
暂无分享，去创建一个
I. Lowy | K. Papadopoulos | I. Braña | A. Naing | S. Formenti | D. Cho | S. Jabbour | D. Rischin | J. Baranda | G. Falchook | W. Fury | M. Fury | M. Gil-Martin | E. Stankevich | J. Hou | S. Yoo | Jingjin Li | K. Moore | A. González-Martín | M. Mathias | M. Feng | N. A. Yama-Dang | Wen Fury